A detailed history of Blackstone Inc transactions in Context Therapeutics Inc. stock. As of the latest transaction made, Blackstone Inc holds 2,440,330 shares of CNTX stock, worth $2.68 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,440,330
Previous 1,838,709 32.72%
Holding current value
$2.68 Million
Previous $3.68 Million 30.08%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.79 - $2.66 $1.08 Million - $1.6 Million
601,621 Added 32.72%
2,440,330 $4.78 Million
Q2 2024

Aug 14, 2024

BUY
$1.24 - $2.19 $2.28 Million - $4.03 Million
1,838,709 New
1,838,709 $3.68 Million

Others Institutions Holding CNTX

About Context Therapeutics Inc.


  • Ticker CNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,966,100
  • Market Cap $17.6M
  • Description
  • Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therape...
More about CNTX
Track This Portfolio

Track Blackstone Inc Portfolio

Follow Blackstone Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blackstone Inc, based on Form 13F filings with the SEC.

News

Stay updated on Blackstone Inc with notifications on news.